We have been in the import game for over 10 years
It is based on a deep understanding of the extensive clinical evidence and high-quality studies (like the STEP trials) that demonstrate a clear benefit for a specific purpose, in this case, weight management
The NIH launched a study in 1996 that would largely define clinical thinking around treatment moving forward
In 2021, the FDA approved Novo Nordisk's Wegovy, a slight reformulation of Ozempic designed specifically for weight loss, which drove a huge spike in public awareness of GLP-1 agonists
As a result, more people across Pennsylvania can now safely access medical weight loss treatment from home
We take every measure to ensure you receive exactly what has been prescribed no more, no less with the quality and care you deserve